skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Lithium inhibits terminal differentiation of erythroleukemia cells: evidence for a pre-commitment priming event

Journal Article · · Exp. Cell Res.; (United States)

Lithium has been found to be a novel inhibitor of the terminal differentiation of Friend murine erythroleukemia cells. A general method for the quantitative analysis of differentiation inhibitors has been developed and used to compare the site of inhibition by lithium with that by vanadate. Lithium inhibits the commitment to differentiation (K/sub 1/2/approx.10 mM) induced by DMSO (dimethylsulfoxide) at non-toxic concentrations that have only a small effect on the rate of proliferation. Inhibition is reversible and probably requires entry of Li/sup +/ into the cell, since it is blocked by high KCl in the medium. LiCl is most effective when present during the first 10 h of DMSO treatment, before commitment is initiated. Computer-assisted analysis of the kinetics of commitment demonstrate that inhibition by lithium is best described by including a lithium-sensitive priming event, which occurs with high probability prior to commitment.

Research Organization:
Univ. of Rochester, NY
OSTI ID:
6515859
Journal Information:
Exp. Cell Res.; (United States), Vol. 168:2
Country of Publication:
United States
Language:
English

Similar Records

Assessment of polyamines in the control of cell growth and differentiation in cultured Friend erythroleukemia cells
Conference · Sun Jan 01 00:00:00 EST 1978 · OSTI ID:6515859

PU.1 silencing leads to terminal differentiation of erythroleukemia cells
Journal Article · Fri Apr 22 00:00:00 EDT 2005 · Biochemical and Biophysical Research Communications · OSTI ID:6515859

Glucocorticoids inhibit coordinated translation of. cap alpha. - and. beta. -globin mRNAs in Friend erythroleukemia cells
Journal Article · Thu Dec 01 00:00:00 EST 1983 · Arch. Biochem. Biophys.; (United States) · OSTI ID:6515859